Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

25.09 USD +0.46 (+1.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,495,177
Open 24.59
Bid (Size) 24.70 (3)
Ask (Size) 26.44 (1)
Prev. Close 24.63
Today's Range 24.52 - 25.11
52wk Range 15.35 - 25.47
Shares Outstanding 160,451,949
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Alkermes Celebrates Alcoholics Anonymous Founders Day
Tags Events, Media & Communications Health & Healthcare Life Science
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes: Diversity Strengthens Our Culture
Tags Reduced Inequalities Workplace Inclusion Alkermes
From 3BL Media: Corporate Social Responsibility, Energy and Health News

Performance

YTD
+27.10%
+27.10%
1 Month
+13.63%
+13.63%
3 Month
+27.04%
+27.04%
6 Month
+13.53%
+13.53%
1 Year
+53.74%
+53.74%

More News

Read More
Alkermes Presents New Data on Nemvaleukin Alfa at 2021 American Society of Clinical Oncology Annual Meeting
From PR Newswire
Alkermes to Take Part in the Goldman Sachs Annual Global Healthcare Conference
From PR Newswire
"I'm Incredibly Proud to Work at a Company Whose Mission Is To Help Families Like Mine"
Tags Disease Awareness Jobs Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
From PR Newswire
Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs
Tags Market News ALPN BIIB
From Motley Fool
Stocks With Rising Relative Strength: Alkermes
From Investor's Business Daily
Alkermes Shares Move Higher On FDA Approval Of Schizophrenia, Bipolar Med
Tags FDA bipolar disorder Biotech
From Benzinga
Thinking about trading options or stock in Alkermes, GameStop, Nio, Advanced Micro Devices, or Salesforce?
From PR Newswire
Alkermes Trying To Close In On Key Technical Measure
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.